Genentech and Vernalis partnered to use Vernalis' fragment and structure-based drug discovery platform against an undisclosed target

Vernalis plc

U.K. / Small-Cap Biopharma (<$1 billion)

$164.4m on 01/04/2013 [market cap]

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Genentech Inc.

U.S. / Large-Cap Biopharma (>=$50 billion)

$98,687.2m on 03/20/2009 [market cap]

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Roche

Switzerland / Large-Cap Biopharma (>=$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced